Cresco Labs President Joe Caltabiano Resigns Effective Immediately

Cresco Labs (CSE: CL) has seen one of its co-founders resign as of this morning. Originally reported late last night by MJBizDaily, Cresco Labs announced this morning that co-founder and president Joe Caltabiano will be resigning from his role as president with the company.

Little detail was provided by Cresco on the reason for Caltabiano’s departure, aside from the fact that he notified the board of his decision to resign effective immediately. Caltabiano’s responsibilities will be assumed by that of current CEO and co-founder Charlie Bachtell, as well as “other members” of Cresco’s leadership team.

It is believed that Caltabiano will remain on Cresco’s board of directors.

Cresco Labs last traded at $6.04 on the CSE.


Information for this briefing was found via Sedar and Cresco Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold

Recommended

Antimony Resources Expands Footprint as Soil Sampling Lights Up Ground South of Bald Hill

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Related News

Cresco Labs Acquires Three Pennsylvania Dispensaries For US$90 Million

Cresco Labs (CE: CL) is expanding its footprint in Pennsylvania. The expansion however does not...

Thursday, September 23, 2021, 09:00:20 AM

Origin House Expects to Nearly Double First Quarter Revenues

Origin House (CSE: OH) announced preliminary revenue figures for the second quarter of 2019 today,...

Thursday, July 18, 2019, 11:07:06 AM

Cresco Labs Posts $214.4 Million In Revenue, $23.7 Million Net Loss In Q1 2022

Cresco Labs (CSE: CL) released its Q1 2022 financials, highlighting a quarterly revenue of $214.4 million....

Wednesday, May 18, 2022, 11:28:00 AM

Cresco Labs Finalizes Acquisition of Hope Heal Health

Cresco Labs (CSE:CL), has received change in ownership approval from the Massachusetts Cannabis Control Commission,...

Friday, February 7, 2020, 09:42:52 AM

Cresco Labs To Pay US$2.0 Billion In Stock To Acquire Columbia Care

Consolidation within the US cannabis space continued this morning with the proposed combination of Columbia...

Wednesday, March 23, 2022, 07:58:57 AM